In whatthey are claimingis a world first , biotech company BioViva has annunciate that they have used cistron therapy to lengthen the caps on the last of DNA – known as telomeres – in the CEO of their party , Elizabeth Parrish .
entail in the age outgrowth , telomeres protect the DNA . BioViva claims that their experimental treatments that were given to Parrish over a yr ago , used initially against loss of muscle mass and stem cell depletion , have had the result instead of increase the lengths of the telomeres in her white blood prison cell . Others arehighly unbelieving .
Telomeresare found on the death of each chromosome , which contain all the familial information that codes for the organism , and protect the desoxyribonucleic acid from natural wear and snag . conceive of them as the little bit of plastic on the end of shoelaces that prevent them from becoming unraveled . As a cubicle water parting and the chromosome are copied , a little bit gets shave off each telomere meaning that as you maturate , they get shorter and inadequate until they reach a vital distance and the cell stops separate or conk out .
BioViva CEO Elizabeth Parrish claims that the cistron therapy she received successfully lengthened her telomeres.10,000x / YouTube
These cap and their shortening have been variously linked to aging and disease , and so the theory goes that if you could prevent , or somehow invert this , it could also prevent the aging process . This is not as extraordinary as it sounds , as something to this upshot has already been wield on human cells cultured in the laboratory . One team atStanford University Medical Center , for exemplar , precede a modified type of RNA , which they engineered to extend the telomere . They successfully wangle to get the RNA to repeal the shortening of telomeres in skin cell , give up them to divide more than 40 time more than untreated cubicle .
This method , however , is only designed to help extend the spirit of genteel human cells used in drug examination or disease modeling , and after a few day the protective impression wore off . This new announcement from BioViva claim to have made the leap from petri dish to human , enjoin that they have managed to lengthen the telomere in Parrish ’s blank blood cells . Unable to conduct the discourse in the U.S. , Parrish flew to Colombia to get it done , bring to the murky circumstances surround the therapy , of which no other point seem to have been release .
Without a print study or sovereign substantiation , a sampling sizing of one – and that one being the chief executive officer of the fellowship in query and not in a clinical tribulation – it is unacceptable to say whether or not they have really achieved this . It may simply be some form of public relations safari or , asothers have putit , “ a new low in medical quackery . ” ego - experimentation is not unheard of , with some who undertake it even going on to win a Nobel Prize , but that comes with hard data and evidence . Both are so far missing here .
The researchers over at BioViva are saying that they will now continue to test Parrish for potentially age to come up , though some have already hit out against the experiment , and even phallus of the company ’s own scientific advisory boardhave distance themselvesfrom Parrish and the experiment . It waits to be seen if any other data about the procedure is released by BioViva , and whether that will resist up to examination .
